Bladder Cancer
Precise diagnosis and treatment of non-muscle invasive bladder cancer - A clinical perspective.
February 22, 2023
Comprehensive optimization of urinary exfoliated tumor cells tests in bladder cancer with a promising microfluidic platform.
February 22, 2023
Follicular Helper T Cells Predict Clinical Efficacy of PD-1 Inhibition in MIBC - Expert Commentary
February 21, 2023
Efficacy of chemotherapy on overall survival in metastatic sarcomatoid bladder cancer patients.
February 21, 2023
Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis.
February 21, 2023
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort.
February 20, 2023
Diagnostic Performance of Biomarkers for Bladder Cancer Detection Suitable for Community and Primary Care Settings: A Systematic Review and Meta-Analysis.
February 16, 2023
Clinical features of patients with MTAP-deleted bladder cancer.
February 16, 2023
Adherence to lifestyle recommendations after non-muscle invasive bladder cancer diagnosis and risk of recurrence.
February 15, 2023
Robotic Versus Open Cystectomy for Bladder Cancer: Synthesizing the Data from Current Systematic Reviews and Meta-Analyses.
February 14, 2023
Performance of Node-RADS Scoring System for a Standardized Assessment of Regional Lymph Nodes in Bladder Cancer Patients.
February 14, 2023
Computational Analysis of N6-Methyladenosine Regulators and Long Non-Coding RNAs in Bladder Cancer - Expert Commentary
February 13, 2023